Liquidia Technologies (NASDAQ:LQDA) Trading Down 4.4% - What's Next?

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) traded down 4.4% during mid-day trading on Wednesday . The company traded as low as $13.13 and last traded at $13.18. 194,006 shares changed hands during mid-day trading, a decline of 84% from the average session volume of 1,219,174 shares. The stock had previously closed at $13.78.

Wall Street Analyst Weigh In

Several research firms have commented on LQDA. Wall Street Zen upgraded Liquidia Technologies from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. Wells Fargo & Company increased their price target on Liquidia Technologies from $23.00 to $25.00 and gave the stock an "overweight" rating in a research report on Thursday, June 12th. Scotiabank lifted their price objective on Liquidia Technologies from $36.00 to $37.00 and gave the company a "sector outperform" rating in a report on Wednesday, May 28th. Bank of America decreased their price objective on Liquidia Technologies from $25.00 to $23.00 and set a "buy" rating for the company in a research note on Wednesday, June 11th. Finally, BTIG Research reiterated a "buy" rating on shares of Liquidia Technologies in a research note on Tuesday, May 27th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, Liquidia Technologies currently has an average rating of "Moderate Buy" and a consensus target price of $26.89.

Liquidia Technologies Price Performance

The company has a 50-day moving average of $15.25 and a 200 day moving average of $14.25. The company has a quick ratio of 2.91, a current ratio of 2.93 and a debt-to-equity ratio of 2.08. The stock has a market capitalization of $1.14 billion, a PE ratio of -8.40 and a beta of 0.04.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.42) by ($0.03). The company had revenue of $3.12 million during the quarter, compared to analysts' expectations of $3.23 million. Liquidia Technologies had a negative net margin of 903.80% and a negative return on equity of 177.91%. Sell-side analysts predict that Liquidia Technologies, Inc. will post -1.51 EPS for the current year.

Insiders Place Their Bets

In other news, General Counsel Russell Schundler sold 5,964 shares of the firm's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $13.57, for a total transaction of $80,931.48. Following the completion of the transaction, the general counsel now directly owns 570,301 shares in the company, valued at $7,738,984.57. This trade represents a 1.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Rajeev Saggar sold 2,450 shares of the business's stock in a transaction on Monday, April 21st. The stock was sold at an average price of $13.67, for a total transaction of $33,491.50. Following the completion of the transaction, the insider now owns 263,152 shares of the company's stock, valued at approximately $3,597,287.84. This trade represents a 0.92% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,138 shares of company stock valued at $450,233 over the last quarter. 30.10% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Hurley Capital LLC purchased a new position in shares of Liquidia Technologies in the 1st quarter valued at about $32,000. GAMMA Investing LLC raised its holdings in Liquidia Technologies by 65.6% in the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock valued at $44,000 after acquiring an additional 1,173 shares in the last quarter. Steward Partners Investment Advisory LLC purchased a new stake in shares of Liquidia Technologies in the 4th quarter valued at approximately $59,000. Quarry LP purchased a new stake in shares of Liquidia Technologies in the 1st quarter valued at approximately $79,000. Finally, Summit Investment Advisors Inc. raised its holdings in shares of Liquidia Technologies by 35.0% in the 4th quarter. Summit Investment Advisors Inc. now owns 6,632 shares of the company's stock valued at $78,000 after purchasing an additional 1,719 shares in the last quarter. 64.54% of the stock is currently owned by hedge funds and other institutional investors.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.